These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7480563)

  • 21. [Prostaglandin E1 in the long-term treatment of erectile dysfunction].
    Vrabec J
    Bratisl Lek Listy; 1992 Oct; 93(10):545-6. PubMed ID: 1288824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of intracavernous injection and audiovisual sexual stimulation during real-time pharmacopenile doppler ultrasonography in vasculogenic erectile dysfunction.
    Tang J; Tang Y; Dai Y; Lu L; Jiang X
    Urol Int; 2013; 90(4):460-4. PubMed ID: 23548406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does compression of the base of the penis improve the efficacy of intracavernosal injection of prostaglandin E1 for impotence? A randomized controlled study.
    el-Saleh JC; Keogh EJ; Chew KK; Earle CM; Lee JL; Wearmouth JW
    Int J Impot Res; 1995 Mar; 7(1):23-31. PubMed ID: 7670590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penile scarring with intracavernous injection therapy using prostaglandin E1: a risk factor analysis.
    Chen RN; Lakin MM; Montague DK; Ausmundson S
    J Urol; 1996 Jan; 155(1):138-40. PubMed ID: 7490812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Classification of patterns of nocturnal penile tumescence with continuous monitoring of penile rigidity: analysis of various factors affecting erection].
    Yasumoto R; Kawano M; Tsurusaki K; Yoneda Y; Ishii K; Khono T; Kumata N; Fukui J; Hayashi S; Tsujino T; Umeda M
    Hinyokika Kiyo; 1996 Apr; 42(4):285-8. PubMed ID: 8693961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma levels of cavernous and systemic norepinephrine and epinephrine in men during different phases of penile erection.
    Becker AJ; Uckert S; Stief CG; Truss MC; Machtens S; Scheller F; Knapp WH; Hartmann U; Jonas U
    J Urol; 2000 Aug; 164(2):573-7. PubMed ID: 10893646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose.
    von Heyden B; Donatucci CF; Kaula N; Lue TF
    J Urol; 1993 May; 149(5 Pt 2):1288-90. PubMed ID: 8479018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of cavernosal peak systolic velocity in the flaccid penis.
    Kahvecioğlu N; Kurt A; Ipek A; Yazicioğlu KR; Akbulut Z
    Adv Med Sci; 2009; 54(2):233-8. PubMed ID: 19808161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Honeymoon impotence: psychogenic or organic in origin?
    Usta MF; Erdoğru T; Tefekli A; Köksal T; Yücel B; Kadioğlu A
    Urology; 2001 Apr; 57(4):758-62. PubMed ID: 11306399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A study on the erectile response with the vacuum constriction device compared with intracavernous injection of a vasoactive drug].
    Wada H; Sato Y; Suzuki N; Horita H; Shibuya A; Adachi H; Tsukamoto T; Kumamoto Y; Tanda H
    Nihon Hinyokika Gakkai Zasshi; 1995 Feb; 86(2):321-4. PubMed ID: 7897934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracavernous injection of prostaglandin E1: the application to cavernosography and penile blood flow measurement for the diagnosis of venogenic impotence.
    Ishigooka M; Irisawa C; Watanabe H; Adachi M; Ishii N; Nakada T
    Urol Int; 1991; 46(2):193-6. PubMed ID: 2053230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group.
    Linet OI; Ogrinc FG
    N Engl J Med; 1996 Apr; 334(14):873-7. PubMed ID: 8596569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of duplex ultrasonography and nocturnal penile tumescence in evaluation of impotence.
    Allen RP; Engel RM; Smolev JK; Brendler CB
    J Urol; 1994 Jun; 151(6):1525-9. PubMed ID: 8189562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience with intracavernous PGE-1 in the treatment of erectile dysfunction: dose considerations and efficacy.
    Ismail M; Abbott L; Hirsch IH
    Int J Impot Res; 1997 Mar; 9(1):39-42. PubMed ID: 9138057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of stress and coping upon the diagnostic intracavernous injection in men with erectile dysfunction.
    van der Borght W; Vanderschueren D; Demyttenaere K
    J Psychosom Res; 1995 Oct; 39(7):865-73. PubMed ID: 8636918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcitonin-gene-related peptide: a possible role in human penile erection and its therapeutic application in impotent patients.
    Stief CG; Wetterauer U; Schaebsdau FH; Jonas U
    J Urol; 1991 Oct; 146(4):1010-4. PubMed ID: 1895414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma levels of angiotensin II during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunction.
    Becker AJ; Uckert S; Stief CG; Scheller F; Knapp WH; Hartmann U; Jonas U
    Urology; 2001 Nov; 58(5):805-10. PubMed ID: 11711372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of intracavernosal sodium nitroprusside in impotence.
    Tarhan F; Kuyumcuoğlu U; Kolsuz A; Ozgül A; Cangüven O
    Urol Int; 1996; 56(4):211-4. PubMed ID: 8776816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Grower or shower? Predictors of change in penile length from the flaccid to erect state.
    Yafi FA; Alzweri L; McCaslin IR; Libby RP; Sangkum P; Sikka SC; Hellstrom WJG
    Int J Impot Res; 2018 Nov; 30(6):287-291. PubMed ID: 30068977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erectile dysfunction in men with and without diabetes mellitus: a comparative study.
    Bancroft J; Gutierrez P
    Diabet Med; 1996 Jan; 13(1):84-9. PubMed ID: 8741818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.